Yonsei Medical Journal · 2022 · 49 citations · 19 references
PharmacyInfectious DiseasesInternal MedicineBehavioral HealthHealth PsychologySymptom ScienceAnxiety SymptomsHealth-related Quality Of LifeHealth-related Quality Of Life MeasurementPost-traumatic Stress DisorderSymptom AssessmentSymptom Burden AssessmentAnxiety Symptom AssessmentEuroqol Five DimensionsGeneralized Anxiety Disorder AssessmentGeneralized Anxiety SymptomsLong-term CoursePersistent SymptomsProspective Cohort DataSelf-report Anxiety Questionnaires
PURPOSE: Globally, concerns have grown regarding the long-term effects of novel coronavirus disease (COVID-19) infection. Therefore, we evaluated the long-term course of persistent symptoms and patient quality of life. MATERIALS AND METHODS: This prospective cohort study was conducted at a single tertiary university hospital from August 31, 2020 to March 29, 2021 with adult patients followed at 6 and 12 months after acute COVID-19 symptom onset or diagnosis. Clinical characteristics, self-reported symptoms, EuroQol 5 dimension 5 level (EQ5D-5L) index scores, Korean version of the Patient Health Questionnaire-9 (PHQ-9), Korean version of the Posttraumatic Stress Disorder Checklist-5 (PCL-5-K), and Generalized Anxiety Disorder-7 (GAD-7) were investigated. Symptom persistent or non-persistent groups were defined according to persistency of COVID-19 related symptoms or signs after acute COVID-19 infection, respectively. RESULTS: =0.051). CONCLUSION: Neuropsychiatric symptoms were the major COVID-19-related symptoms after 12 months from acute COVID-19 infection, reducing quality of life.
19
Valentina O. Püntmann, Maria Ludovica Carerj, Imke Wieters et al. · JAMA Cardiology · 2020 · 2.3K citations · Full text
Veterinary Medicine, Infectious Diseases, Internal Medicine +10
The Science Underlying COVID-19
Peter P. Liu, Alice Blet, David Smyth et al. · Circulation · 2020 · 835 citations